Upgrade to SI Premium - Free Trial

Aclaris Therapeutics (ACRS)

5.74 -0.12 (2.05%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26 *Est.)

Latest Headlines

Form 8-K Aclaris Therapeutics, For: Aug 06 August 6, 2026 5:15 PM - SEC Filing Form S-3ASR Aclaris Therapeutics, August 6, 2026 5:08 PM - SEC Filing Form 10-Q Aclaris Therapeutics, For: Jun 30 August 6, 2026 4:37 PM - SEC Filing FDA grants fast track status to Aclaris drug for lichen planus August 6, 2026 4:36 PM - StreetInsider Aclaris Therapeutics Receives Fast Track Designation for Modzatinib (ATI-2138) for Moderate to Severe Lichen Planus (LP) August 6, 2026 4:35 PM - StreetInsider Form 8-K Aclaris Therapeutics, For: Aug 06 August 6, 2026 7:15 AM - SEC Filing Aclaris Therapeutics (ACRS) Tops Q2 EPS by 1c August 6, 2026 7:05 AM - StreetInsider Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update August 6, 2026 6:59 AM - StreetInsider Form 4 Aclaris Therapeutics, For: Aug 01 Filed by: Kolbeck Roland Wilhelm August 4, 2026 5:03 PM - SEC Filing Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: Molineaux Christopher P. June 8, 2026 4:15 PM - SEC Filing Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: MILANO VINCENT June 8, 2026 4:15 PM - SEC Filing Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: Humphries William D. June 8, 2026 4:15 PM - SEC Filing Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: Mehra Anand June 8, 2026 4:15 PM - SEC Filing Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: SCHIFF ANDREW N June 8, 2026 4:15 PM - SEC Filing Form 4 Aclaris Therapeutics, For: Jun 04 Filed by: GOWEN MAXINE June 8, 2026 4:15 PM - SEC Filing Form 8-K Aclaris Therapeutics, For: Jun 04 June 4, 2026 4:02 PM - SEC Filing Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference May 28, 2026 8:30 AM - Globe NewsWire Full Article List